Robert J. Bitterman
Overview
Robert J. Bitterman received an average of $94K in total compensation, including $63K in salary, at RXi Pharmaceuticals between 2021 and 2022.
Source: SEC filing on June 9, 2023.
Related executives
We found six more executives who work or worked at RXi Pharmaceuticals.
Gerrit Dispersyn
RXi Pharmaceuticals
Chief Executive Officer
Geert Cauwenbergh
RXi Pharmaceuticals
Former interim Principal Executive and Financial Officer
John Barrett
RXi Pharmaceuticals
Former Chief Development Officer
Alexey Eliseev
RXi Pharmaceuticals
Former Chief Business Officer
Pamela Pavco
RXi Pharmaceuticals
Former Chief Development Officer
Anastasia Khvorova
RXi Pharmaceuticals